Acute Myelogenous Leukemia with t(8;21)—Identification of a Specific Immunophenotype

References

• Bitter, M.A., Le Beau, M.M., Rowley, J.D., Larson, R.A., Golomb, H.M. and Vardiman, J.W. (1987) "Association between morpho-logy, karyotype and clinical features in myeloid leukemias", Human Pathology 18, 211–225.
   PubMed Web of Science ®Google Scholar
• Fenaux, P., Preudhomme, C., Lab, U., Morel, P., Beuscart, R. and Banters, F. (1989) "Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases", British Journal of Haematology 73, 61–67.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. and Ohki, M. (1993) "The (8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript", EMBO Journal 12, 2715–2721.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., Bim, D., Erickson, P., Gao, J., Le Beau, M.M., Drabldn, H.A. and Rowley, J.D. (1993) "Detection of DNA rearrangements in AML1 and ETO loci and of an AMLI/ETO in RNA in patients with t(8;21) AML", Blood 81, 883–888.
   PubMed Web of Science ®Google Scholar
• Friedman, A.D. (1999) "Leukemogenesis by CBF oncoproteins", Leukemia 13, 1932–1942.
   PubMed Web of Science ®Google Scholar
• Downing, J.R. (1999) "The AML1-ETO chimeric protein transcription factor in acute myeloid leukemia: biology and clinical significance", British Journal of Haematology 106, 296–308.
   PubMed Web of Science ®Google Scholar
• Downing, J.R. (2001) "AMLUCBFfil transcription complex: its role in normal hematopoiesis and leukemia", Leukemia 15, 664–665.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) "World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues: report of the Clinical Advisory Meeting-Airlie House, Virginia, November 1997", Journal of Clinical Oncology 17, 3835–3849.
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia, 1982(1984) "Translocation (8;21)(q22;q22) in acute nonlymphcytic leukemia", Cancer Genetic and Cytogenetic 11, 284–287.
   Google Scholar
• Byrd, J.C., Dodge, R.K., Carroll, A., Baer, M.R., Edwards, C., Sternberg, J., Qumsiyeh, M., Moore, J.0., Mayer, R.J., Davey, F., Chiffer, C.A. and Bloomfield, C.D. (1999) "Patients with t(8;21) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered", Journal of Clinical Oncology 17, 3767–3775.
   Google Scholar
• Group Francais de Cytogénetique Hématologique (GFCH)(1990) "Cute myeloid leukemia with an 8;21 translocation: a report on 148 cases from Group Franeais de Cytogenetique Hematologique", Cancer Genedque and Cytogenetic 44, 169–179.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T, Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1985) "Proposed revised criteria for classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group", Annals of Internal Medicine 103, 620–625.
   PubMed Web of Science ®Google Scholar
• Swirsky, D.M., Li, Y.S., Matthews, J.G., Flemans, R.J., Rees, J.K.H. and Hayhoe, F.G.J. (1984) "8;21 translocation in acute granulocytic leukemia: cytological, cytochemical and clinical features", British Journal of Haematology 56, 199–213.
   PubMed Web of Science ®Google Scholar
• Berger, R., Bernheim, A., Daniel, M.T., Valensi, F., Sigaux, F. and Flandrin, G. (1982) "Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia", Blood 59, 171–178.
   PubMed Web of Science ®Google Scholar
• Haferlach, T., Bennett, J.M., Loffier, H., Gassamann, W., Andersen, J.W., Tuzuner, N., Casslleth, P.A., Fonatsch, C., Schoch, C., Schlegelberger, B., Becher, R., Thiel, E., Ludwig, W.D., Sauerland, M.C., Heinecke, A. and Buchner, T. (1996) "Acute myeloid leukemia with translocation (8;21). cytomorphology, dysplasia and prognostic factors in 41 cases", Leukemia and Lymphoma 23, 227–234.
   PubMed Web of Science ®Google Scholar
• Loftier, H., Gassmann, W. and Haferlach, T. (1995) "AML-Ml and M2 with eosinophilia and AML-M4eo: diagnosis and clinical aspects", Leukemia and Lymphoma 18\(Suppl. 1), 61–63,
   Google Scholar
• Nucifora, G., Dickstein, J.I., Torbenson, V., Roulstone, D., Rowley, J.D. and Vardiman, J.W. (1994) "Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21)", Leukemia 8, 1533–1538.
   PubMed Web of Science ®Google Scholar
• Andrieu, V., Radford-Weiss, I., Troussard, X., Chane, C., Valensi, F., Guesnu, M., Harldnd, E., Viguier, F., Dreyfus, F., Varet, B., Flandrin, G. and Macintyre, E. (1996) "Molecular detection of t(8;21)/AMLI-ETO in AML MI/M2: correlation with cytogenetics, morphology and immunophenotype", British Journal of Haematol-ogy 92, 855–865.
   PubMed Web of Science ®Google Scholar
• Kita, K., Nakase, K., Miwa, H., Masuya, M., Nishii, K., Morita, N., Takakura, N., Otsuji, A., Shirakawa, S., Ueda, T., Nasu, K., Kyo, T., Dohy, H. and Kamada, N. (1992) "Phenotypical characteristics of acute myelocytic leukemia associated with t(8;21) chromosomal abnormality: frequent expression of immature B-cell antigens together with stem cell antigen CD34", Blood 80, 470–477.
   PubMed Web of Science ®Google Scholar
• Hurwitz, C.A., Raimondi, S.C., Head, D., Krance, R., Micro, J. Jr, Kalwinsky, D.K., Ayers, G.D. and Behm, F.G. (1992) "Distinctive inununophenotypic features of 1.(8;21)(q22;q22) acute myeloblastic leukemia in children", Blood 80, 3182–3188.
   PubMed Web of Science ®Google Scholar
• Kita, K., Shirakawa, S. and Kamada, N. (1994) "Cellular characterstics of acute myeloblastic leukemia associated with t(8;21)(q22;q22)", Leukemia and Lymphoma 13, 229–234.
   PubMed Web of Science ®Google Scholar
• Porwil-MacDonald, A., Janossy, G., Ivory, K., Swirsky, D., Peters, R., Wheatley, K., Walker, H., Turker, A., Goldstone, A.H. and Burnett, A. (1996) "Leukemia associated changes identified by quantitative flow cytometry. W. CD34 overexpression in acute myeIogenous leukemia M2 with 48;21)", Blood 87, 1162–1169.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galion, D.A., Gralnick, H.R. and Sultan, C. (1985) "Criteria for diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French—American—British Cooperative Group", Annals of Internal Medicine 103,460–462,
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galion, D.A., Gralnick, H.R. and Sultan, C. (1991) "Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0)", British Journal of Haematology 78, 325–329.
   PubMed Web of Science ®Google Scholar
• Horsman, D.E., Gascoyne, R.D., Coupland, R.W., Coldrnan, A. and Adomat, S.A. (1995) "Comparison of cytogenetic analysis, Southern analysis and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma", American Journal of Clinical Pathology 103, 472–478.
   PubMed Web of Science ®Google Scholar
• ISCN (1991) In: Mitelman, F., ed, Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature (S. Kargar, Basel).
   Google Scholar
• ISCN (1991) In: Mitelman, F., ed, An International System for Human Cytogenetic Nomenclature (S. ICargar, Basel).
   Google Scholar
• Morton, R.F. and Hebei, J.R. (1990) "Screening", A Study Guide to Epidemiology and Biostatics, 2nd Ed. (Aspen Publishers, Gaithersburg, MD) pp 63–69.
   Google Scholar
• Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, K., Vardiman, J., Lister, T.A. and Bloomfield, CD. (1999) "World health organization of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting", Journal of Clinical Oncology 17, 3835 —3849.
   PubMed Web of Science ®Google Scholar
• Tien, H-.F., Wang, C-.H., Lin, M-.T., Lee, F-.Y., Liu, M-.C., Chen, Y-.C., Shen, M-.C., Lin, K.H. and Lin, D.T. (1995) "Correlation of cytogenetic results with immunophenotype, genotype, clinical features and Ras mutation in acute myeloid leukemia", Cancer Genetic and Cytogenetic 84,60–68.
   Google Scholar
• Sperling, C., Buchner, T., Creutzig, U., Ritter, J., Harbott, J., Fonatsch, C., Sauerland, C., Mielcarek, Maschmeyer, G., Loftier, H. and Ludwig, W.D. (1995) "Clinical, morphological and cytogenetic implications of CD34 expression in childhood adult de novo AML", Leukemia and Lymphoma 17, 417–426.
   Google Scholar
• Sutherland, R.D., Marsh, J.C.W., Davidson, J., Baker, M.A., Keating, A. and Mellros, A. (1992) "Differential sensitivity of CD34 epitopes to cleavage by pasteurella haemolytica glyco-protease: implication for purification of CD34-positive progenitor cells", Experimental Hematology 20, 590–599.
   PubMed Web of Science ®Google Scholar
• Lanza, F., Moretti, S., Castagnari, B., Latorraca, A., Rigolin, G.M., Bardi, A. and Castoldi, G. (1995) "CD34+ leukemic cells assessed by different CD34 monoclonal antibodies", Leukemia and Lymphoma 18\(Suppl. 1), 25–30.
   PubMed Web of Science ®Google Scholar
• Serke, S. and Huhn, D. (1996) "Expression of class I, II and III epitopes of CD34 antigen by normal and leukemic hematopoietic cells", Cytometry 26, 154–160.
   PubMedGoogle Scholar
• Lanza, F., Moretti, S., Castagnari, B., Montanelli, F., Latorraca, A., Ferrari, L., Barth, A., Dominici, M., Campioni, D., Dabusti, M., Piva, N., Lodi, G., Reverberi, R. and Castoldi, G. (1999) "Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute leukemia blasts", Haentatologica 84, 969–977.
   PubMed Web of Science ®Google Scholar
• Wittebol, S., Raymakers, R., Van de Locht, L., Mensik, E. and Witte, T. (1998) "In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to CD34+, lineage-negative fraction", Leukemia 12, 1782–1788.
   PubMed Web of Science ®Google Scholar
• Varell-Garcia, M., Hogan, C.J., Odom, L.F., Murata-Collins, J.L., All, H., Chen, L., Richikind, K., Paslculin, G., Andreeff, M., Brizard, A., McGavran, L., Gemmill, R.M., Berger, R. and Drabkin, H.A. (2001) "Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting", Leukemia 15, 1408–1414.
   PubMed Web of Science ®Google Scholar
• Seymour, J.F. Pierce, S.A., Kantrajian, H.M., Keating, M.J. and Estey, E.H. (1994) "Investigation of karyotype and clinical features in patients with acute leukemia blasts expressing neural cell adhesion molecule (CD56)", Leukemia 8, 823–826.
   Google Scholar